Shalby Ltd - 540797 - Notice Of 18Th Annual General Meeting To Be Held On 26-Sep-2022 At 4:00 PM Through Video Conferencing (VC).
Notice of 18th Annual General Meeting to be held on 26-Sep-2022 at 4:00 PM through Video Conferencing (VC).03-09-2022
03-09-2022
Shalby Ltd - 540797 - Intimation Of Book Closure
Shalby Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 21-Sep-2022 to 26-Sep-2022 for the purpose of Dividend and 18th AGM.29-08-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for 18th Annual General Meeting {AGM) {prior to sending AGM Notice & Annual Report)- Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.27-08-2022
Shalby Ltd - 540797 - Intimation Of 18Th Annual General Meeting, Book Closure, Cut-Off Date, E-Voting Period And Dividend.
Intimation of 18th Annual General Meeting, Book closure, Cut-off Date, e-voting period and Dividend. Annual General Meeting scheduled on September 26, 2022.25-08-2022
Shalby Ltd - 540797 - Further Subscription By Mars Medical Devices Limited (WOS Of Shalby Ltd) In Shalby Global Technologies Pte. Ltd., Singapore
Further Subscription of 1,80,000 equity shares of SGD 1 by Mars Medical Devices Limited (WOS of Shalby Ltd) In Shalby Global Technologies Pte. Ltd., Singapore22-08-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Analysts/Institutional Investor Meet/Con. Call held on July 28, 2022 for discussion on Unaudited financial results for quarter ended June 30, 2022.01-08-2022
Shalby Ltd - 540797 - Shalby Enters Into Partnership With Australian Health Ed-Tech Company - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('The SEBI LODR')
Shalby Enters into Partnership with Australian Health Ed-Tech Company27-07-2022
Shalby Ltd - 540797 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper publication of Unaudited Financial Results (Standalone and Consolidated) for quarter ended June 30, 2022.27-07-2022
Q1FY23 Quarterly Result Announced for Shalby Ltd.
Healthcare Facilities firm Shalby Announced Q1FY23 Result : Shalby Hospital Business Registered Quarterly Revenues of Rs. 1,810 million up by 19%, and EBITDA of Rs. 428 million up by 32% with margins of 24%, primarily driven by increase in InPatients count by 15% and Total Surgery count up by 30% quarter on quarter basis. Total Revenues of Rs. 1,810 million, growth of 19% QoQ EBITDA of Rs. 426 million with EBITDA margins of 24% Profit After Tax was Rs. 214 million, growth of 36% QoQ Basic EPS of Rs. 1.99, growth of 37% QoQ Bed occupied during the quarter were 557, with occupancy rate of 45% In patients count of 11,044, growth of 15% QoQ Total Surgery count of 7,211, growth of 30% QoQ Mr. Shanay Shah, President said: “I am happy to report that Shalby has registered ever highest Revenue in the first quarter of FY23 with high double growth of elective surgeries. During the quarter, a total of 7,211 elective surgeries were performed, grew by 30% QoQ as compared to 5,558 in Q4 FY22. We saw a jump of 15% for In-patients counts in Q1 FY23. Occupied beds increased to 557 up by 12% in Q1 FY23 as compared to 499 in Q4 FY22. ARPOB an ALOS were recorded at Rs.35,304 and 4.08 respectively in Q1 FY23 vis-à-vis Rs 33,707 and 4.12 in the previous quarter. Our core specialty such as Arthroplasty, Oncology, Cardiac Science, Orthopedic, Critical care & General Medicine, and Neurology contributed 84% to the revenues respectively in Q1 FY23. International revenue recorded at Rs 24 million, grew by in 47% QoQ with majority of the patients are flying from Kenya, Tanzania, Uganda, Sudan, UAE, Nepal and Bangladesh in Q1 FY23. Home care business has shown a good pick up with revenue of Rs. 21.5 million, grew by 13% QoQ with patient served count of 5,868 in Q1 FY23. The Shalby Academy vertical also showed great acceptance with 578 students enrolled for various healthcare programs during Q1 FY23. Our Realized Return on Capital Employed from hospital business has increased to 17% in Q1 FY23 from 12% in Q4 FY22. We have closed the quarter with a net cash balance of Rs. 439 million at group level and are well positioned to fund our strategic growth plans. Shalby continued to add many milestones backed by clinical excellence and patient satisfaction. We are proud to make a positive difference in people lives. Result PDF27-07-2022